Clinical Trial Compliance & Operations Tech, IRT, RBQM, RTSM

CLINICAL TRIAL COMPLIANCE & OPERATIONS TECHNOLOGY INSIGHTS

Making AI Work For Clinical Trial Supply
AI is accelerating clinical trials, but supply teams risk falling behind. Explore how smarter planning, data, and experimentation turn AI into real operational impact.
Edge AI Is Reshaping How Clinical Trials Run
Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.

Providing Drug Supply Support In Complex Environments Through IRT

Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
CAR T Study For Blockbuster Drug Granted Therapy Designation

Discover how a pharmaceutical sponsor received support for an EDC and IRT database build and got help with data management and biostatistics.
What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution

Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?

How Analytics Are Shaping The Future Of Clinical Trial Risk Management

Explore how analytics are revolutionizing clinical trial risk management and shaping the future of risk mitigation.
Repositioning Your CDM Team To Meet Digital Trial Demands

Consider these steps when repositioning your clinical data management team to unify cross-functional reviews and align processes and technology to meet the demands of digital trials.
RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk

This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.

How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers

Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
RTSM And Clinical Drug Dispensation

A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution

Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?

5 Trends To Watch This Year

Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.
Aligning Global Standards For ICH E6(R3) And Artificial Intelligence

Global standards and AI are transforming clinical research. Learn why mastering ICH E6(R3) and risk-based compliance is critical for data integrity and future success.
AI In Regulatory Medical Writing: Balancing Innovation With Human Expertise

Artificial intelligence is reshaping regulatory medical writing by accelerating document development while maintaining compliance and scientific rigor, creating faster, regulator-ready submissions without compromising quality.

Helping Biotechs Overcome 4 Key Challenges

Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.
The Power Of Patient Preferences: Technology And Payment Automation

How can you leverage customizable, simplified payment methods and third-party providers to improve patient convenience in your clinical trial?
Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials

A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.

Automation Is Not Just AI

Hassan Khalid of AstraZeneca and Jessica Jolly, a senior data and science executive, talk about the advantages of automation as a result of a Guidance like ICH M11, and why “automation” is not synonymous with AI in this case.
Can CDOs and CDAOs Evolve From Monotonous SOPs & Reg Filings?

Jessica Jolly, a senior data and science executive, is challenging CDOs (chief data officers) and CDAOs (chief data & analytics officers) to stop putting the data science community “to sleep” with the traditional monotonous SOPs, and instead, move more toward autonomous governance by design.
eISF: Industry Standard eRegulatory Software For Clinical Sites

Modernize your study binder processes with Florence eBinders™, offering remote access for sponsor interactions, monitoring, and source data review.

Streamline Financial Management Of Clinical Trials

Enhance your Clinical Trial Payments solution with IQVIA Forecasting to leverage our global expertise and navigate the complexities of payments with ease.
Transforming Clinical Trial Site Forecasting

In today’s ever-evolving clinical trial space, managing the expenses associated with conducting a study is more important – and fraught – than ever before.
Greenphire Patient Payments

esigned for sponsors, CROs, sites, and patients, this modern solution delivers real-time data that supports crucial decisions during investigator grant budgeting, randomization, patient payments, and endpoint collection.